Dr. Ilia S. Zeltser, MD

Dr. Zeltser practices at The Bryn Mawr Urology Group in Rosemont, Pennsylvania.

Dr. Zeltser's NPI, 1689689473, was assigned on July 30, 2006. Dr. Zeltser holds Pennsylvania license MD420018.

Dr. Zeltser's primary practice is The Bryn Mawr Urology Group, at 919 Conestoga Road, Rosemont, PA 19010. The practice phone is (610) 525-6580.

Dr. Zeltser's primary practice is The Bryn Mawr Urology Group in Rosemont, Pennsylvania. Dr. Zeltser is also affiliated with Bryn Mawr Hospital. The medical group on file is MidLantic Urology. Dmand AI also links Dr. Zeltser to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zeltser practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Zeltser's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Zeltser's licenses on file in 2 states: Pennsylvania and Texas.

CMS data shows 4,409 Medicare services from Dr. Zeltser across 23 procedure codes in 2024, for 980 Medicare patients. Medicare paid $249,840 for them.

CMS counts 980 Medicare patients who saw Dr. Zeltser in 2024. The largest group is 65 to 74, with 483 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zeltser's median patient age at 73, with 13% women.

In 2024, Dr. Zeltser wrote 1,346 Medicare Part D claims for 278 patients. 63% of them were for generic drugs. CMS names the drug for 1,266 of them, across 19 drugs with 11 or more claims each, at $3,217,514 in total drug cost. In 2023, CMS named 1,108 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Zeltser for performance year 2024, reported as part of a group. Dr. Zeltser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of prostate resection by Dr. Zeltser, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Zeltser, published from 2011 to 2024. The most frequent topics are Postoperative Complications, Prostatic Neoplasms and Robotic Surgical Procedures. Dr. Zeltser has published most often in Urology. Dr. Zeltser's most frequent co-authors are David E. McGinnis, MD, Andrew Pridjian, MD and Zachary Snow, DO.

CMS Open Payments shows 633 general payments to Dr. Zeltser from 63 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Janssen Pharmaceuticals, Inc paid the most, $66,736.